Cardinal Health
+ Follow
Cardinal Health Competitors & Alternatives
Cardinal Health competitors and alternatives include McKesson Corporation, etc.…
Jump
- Stock Price
- Market Cap
- Employees
-
Income Statement
- Revenue
- Revenue by Product / Services
- Revenue by Geography
- Research and Development
- Operating Income
- Tax Rate (%)
- Net Income
-
Assets & Liabilities | Cash Flow
- Total Assets
- Total Liabilities
- Capital Expenditures (Capex)
-
Profitability
- Operating Income Margin (%)
- Net Income Margin (%)
- EBITDA
- Free Cash Flow (FCF)
-
Ratios
- Return on Equity (ROE)
- Return on Assets (ROA)
- Debt to Equity
-
Valuation
- Enterprise value
- Enterprise value to Revenue
- Enterprise value to EBITDA
Ticker
CAH
MCK
Headquarter
Dublin
,OH
US
Irving
,TX
US
CEO
Mr. Jason M. Hollar
Mr. Brian S. Tyler Ph.D.
Industry
Medical - Distribution
Medical - Distribution
Stock Price
Stock Price
Market Cap
$28.87B
$73.30B
Employees
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Employees
- 46.50K
- 48.00K
- 48.90K
- 75.00K
- 51.00K
- 51.00K
Y/Y
1.69%
3.23%
1.88%
1.32%
32%
0%
Income Statement
Revenue
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Revenue
- $181.36B
- $205.01B
- $226.83B
- $263.97B
- $276.71B
- $308.95B
Y/Y
11.63%
13.04%
10.64%
10.8%
4.83%
11.65%
Revenue by Products / Services
Revenue by Geography
Research and Development
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Research and Development
- -
- -
- -
- $70.00M
- $89.00M
- $179.00M
Y/Y
0%
0%
0%
5.41%
27.14%
101.12%
Operating Income
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Operating Income
- $1.65B
- $727.00M
- $1.24B
- $2.85B
- $4.38B
- $3.91B
Y/Y
10.48%
55.89%
70.98%
19.02%
53.61%
10.77%
Tax Rate (%)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Tax Rate (%)
- -21.00%
- 59.00%
- 29.00%
- 33.00%
- 20.00%
- 17.00%
Y/Y
76.3%
377.97%
50.82%
138.88%
40.74%
15.09%
Net Income
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Net Income
- -$932.00M
- $261.00M
- $852.00M
- $1.11B
- $3.56B
- $3.00B
Y/Y
252.54%
128%
226.44%
125.67%
219.57%
15.67%
Assets & Liabilities | Cash Flow
Total Assets
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Total Assets
- $43.88B
- $43.42B
- $45.12B
- $63.30B
- $62.32B
- $67.44B
Y/Y
1.29%
1.05%
3.92%
2.64%
1.55%
8.22%
Total Liabilities
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Total Liabilities
- $44.58B
- $46.27B
- $48.33B
- $65.09B
- $63.81B
- $69.04B
Y/Y
4.51%
3.78%
4.46%
2.39%
1.97%
8.2%
Capital Expenditures (Capex)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Capital Expenditures (Capex)
- -$387.00M
- -$481.00M
- -$511.00M
- -$535.00M
- -$558.00M
- -$687.00M
Y/Y
3.25%
24.29%
6.24%
16.54%
4.3%
23.12%
Profitability
Operating Income Margin (%)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Operating Income Margin (%)
- 0.91%
- 0.35%
- 0.55%
- 1.08%
- 1.58%
- 1.27%
Y/Y
19.47%
61.54%
57.14%
27.03%
46.3%
19.62%
Net Income Margin (%)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Net Income Margin (%)
- -0.51%
- 0.13%
- 0.38%
- 0.42%
- 1.29%
- 0.97%
Y/Y
234.21%
125.49%
192.31%
123.08%
207.14%
24.81%
EBITDA
2021 | 1310000000.00 |
---|---|
2022 | 126000000.00 |
2023 | 1441000000.00 |
2024 | 1978000000.00 |
2021 | -3596000000.00 |
---|---|
2022 | 3107000000.00 |
2023 | 5735000000.00 |
2024 | 4667000000.00 |
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
EBITDA
- $126.00M
- $1.44B
- $1.98B
- $3.11B
- $5.74B
- $4.67B
Y/Y
90.38%
1043.65%
37.27%
186.4%
84.58%
18.62%
Free Cash Flow (FCF)
2021 | 2029000000.00 |
---|---|
2022 | 2735000000.00 |
2023 | 2358000000.00 |
2024 | 3251000000.00 |
2021 | 3901000000.00 |
---|---|
2022 | 3899000000.00 |
2023 | 4601000000.00 |
2024 | 3627000000.00 |
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Free Cash Flow (FCF)
- $2.74B
- $2.36B
- $3.25B
- $3.90B
- $4.60B
- $3.63B
Y/Y
34.8%
13.78%
37.87%
0.05%
18%
21.17%
Ratios
Return on Equity (ROE)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Return on Equity (ROE)
- 132.01%
- -9.15%
- -26.52%
- -49.03%
- -191.71%
- -152.31%
Y/Y
287.58%
106.93%
189.84%
100.24%
291.01%
20.55%
Return on Assets (ROA)
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Return on Assets (ROA)
- -2.12%
- 0.60%
- 1.89%
- 1.76%
- 5.71%
- 4.45%
Y/Y
254.74%
128.3%
215%
126.39%
224.43%
22.07%
Debt to Equity
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Debt to Equity
- -752.83%
- -164.89%
- -158.48%
- -263.69%
- -308.02%
- -292.29%
Y/Y
316.58%
78.1%
3.89%
99.24%
16.81%
5.11%
Valuation
Enterprise Value
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Enterprise value
- $15.18B
- $25.34B
- $23.91B
- $50.63B
- $52.86B
- $74.27B
Y/Y
22.14%
66.92%
5.65%
46.98%
4.39%
40.51%
Enterprise value to Revenue
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Enterprise value to Revenue
- 0.08
- 0.12
- 0.11
- 0.19
- 0.19
- 0.24
Y/Y
30.25%
47.67%
14.72%
32.64%
0.42%
25.86%
Enterprise value to EBITDA
Years
- 2022
- 2023
- 2024
- 2022
- 2023
- 2024
Enterprise value to EBITDA
- 120.49
- 17.59
- 12.09
- 16.30
- 9.22
- 15.91
Y/Y
709.46%
85.4%
31.26%
270.11%
43.45%
72.66%